Delivery Order SPE2DB24D1205-SPE2DB25FCWCZ
Award Date 4/24/25
Potential Completion Date 5/15/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp has been awarded a delivery order contract by the Defense Logistics Agency (DLA) Medical Supply Chain for the supply of Leqembi 200 mg/2 mL vials. The contract, awarded on September 3, 2025, carries a ceiling value of $1,923.68 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 24, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Leqembi 500 mg/5 ml vials with a ceiling value of $2,887.17 and a firm fixed price. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract utilizes no set-aside designation and represents a competitively awarded...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Leqembi 500 mg/5 ml vials. This is a firm fixed-price delivery order with a ceiling value of $1,399.49 and a completion date of October 15, 2025. The contract was competitively awarded without set-aside designation to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, where the products will...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,560.95 firm fixed-price delivery order is for the supply of LEQEMBI 500 MG/5 ML VIAL 5ML, a medication. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 18, 2025, by the Defense Logistics Agency (DLA) for the supply of LEQVIO 284 mg/1.5 mL syringes with a ceiling value of $16,278.85. This firm fixed-price delivery order, which is scheduled for completion by July 11, 2025, is unset-aside and competitively awarded. The award represents a continuation of the company's substantial role as a critical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a Delivery Order contract valued at $6,592.23 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of the prescription drug LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a period of performance through July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,303.16 by the Defense Logistics Agency's Medical Supply Chain on June 20, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $2,278.50 to AmerisourceBergen Drug Corp under a firm fixed-price contract. This non-set-aside delivery order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a discrete procurement of pharmaceutical products or medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,574.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Leqembi 500 mg/5 mL vial, an FDA-approved monoclonal antibody treatment for early-stage Alzheimer's disease. The contract, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive award to the prime contractor's corporate office located in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $12,740 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on June 18, 2025, with completion scheduled for June 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive...